Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1998 Jun;124(3):441–446. doi: 10.1038/sj.bjp.0701813

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997

Masayuki Asano 1,**, Chie Hatori 1, Hiroe Sawai 1, Shigeru Johki 1, Noriaki Inamura 1, Hiroshi Kayakiri 2, Shigeki Satoh 2, Yoshito Abe 2, Takayuki Inoue 2, Yuki Sawada 2, Tsuyoshi Mizutani 2, Teruo Oku 2, Kunio Nakahara 1
PMCID: PMC1565402  PMID: 9647466

Abstract

  1. The nonpeptide bradykinin (BK) B2 receptor antagonist, FR165649 (8-[2,6-dichloro-3-[N-[(E)-4-(N- methylcarbamoyl)cinnamidoacetyl] -N-methylamino] benzyloxy] -2 - methylquinoline), and agonist, FR190997 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl) cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridylmethoxy)quinoline) have been identified. These compounds have a common chemical structure, and the 2-pyridylmethoxy group is the only structural difference between them.

  2. Both FR165649 and FR190997 displaced [3H]-BK binding to B2 receptors in guinea-pig ileum membranes, with an IC50 of 4.7×10−10M and 1.5×10−9M, respectively. They also displaced [3H]-BK binding to B2 receptors in human lung fibroblast IMR-90 cells, with an IC50 of 1.6×10−9M and 9.8×10−10M, respectively.

  3. In guinea-pig isolated ileum-preparations, FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concentration-response curves to BK on contraction. Analysis of the data produced a nominal pA2 value of 9.2±0.1 (n=5) and a slope of 1.4±0.1 (n=5). On the other hand, FR190997 induced concentration-dependent contraction of guinea-pig ilea with a pD2 of 7.9±0.2 and the contraction was inhibited by a specific peptide bradykinin B2 receptor antagonist, Hoe 140 (D-Arg-[Hyp3, Thi5, D-Tic7, Oic8]BK) in a non-competitive manner.

  4. In IMR-90 cells, FR165649 had no agonistic effect on phosphatidyl inositol (PI) hydrolysis and caused parallel rightward shifts (approximately 200 fold shift at 10−7M) of the concentration-response curves to BK on PI hydrolysis. FR190997 induced concentration-dependent PI hydrolysis in IMR-90 cells with a pD2 of 8.4±0.1, and this effect was inhibited by Hoe 140.

  5. These results indicate that FR165649 and FR190997 are, respectively, a potent bradykinin B2 receptor antagonist and agonist, and that the agonistic activity depends on the small part of the nonpeptide ligand. FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.

Keywords: Bradykinin, nonpeptide antagonist, nonpeptide agonist, B2 receptor, FR165649, FR190997

Full Text

The Full Text of this article is available as a PDF (331.2 KB).


Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES